Published :
Tables : 51
Figures : 46
Category : Healthcare
No. of Pages : 220
Report Code : HC-1070
At Home Diagnostics Market Introduction: At Home Diagnostics Market is calculated to value over USD 7.6 billion by the end of 2028 and register at a CAGR of over 5.4% during the forecast period of 2021-2028. Tests that are performed on human body samples like blood, saliva and urine which can be used for detection of diseases or medical conditions at home are called in-vitro diagnostics or home diagnostics. It is a popular test among the patient population as these tests are cost-effective, quick and confidential. The home diagnostic system is found in the form of a strip, digital monitoring instruments, dip cards, cups and cassettes. Growing awareness of home care testing among the population led to the potential growth of the market. Increasing epidemics of diseases has shifted the focus of the general population towards preventive healthcare rather than curative medicines. It created huge opportunities for manufacturers in this market. It is further augmented by changing demographics and increasing per capita healthcare expenditure due to increasing living standards led to the robust growth of the market. At home, diagnosis plays an important role in the preliminary diagnosis of disease and contained the cost of healthcare expenditure. As they are cost-effective and easy to use, patient adoption is high with limited technical knowledge. All these factors led to the burgeoning growth of the market North America and Europe dominated the global market due to high awareness among the general population. In North America, US accounts 90% market share due to high adoption. In Europe, UK Germany and France dominated the global market due to high penetration among the general population. The Asia Pacific and Latin America is the most opportunistic market for manufacturers due to the large patient population. They both were expected to witness high growth rate during the forecast period. Rest of the World accounts the small fraction of the market and it is expected to account more share during the later phase of the forecast period. Major players included in the At Home Diagnostics Market: • Thermo Fisher Scientific • SYNLAB • Siemens Healthcare Private Limited • Roche Diagnostics • Drägerwerk AG & Co. KGaA • Beckman Coulter, Inc. • Abbott Laboratories • ACON Laboratories Inc. • BTNX Inc. • ARKRAY Inc. • Assure Tech (Hangzhou) co. Ltd. • Bionime Corporation • Quidel Corporation • True Diagnostics Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) At Home Diagnostics Market Segmentation: By Test Type • Glucose Monitoring Devices • Pregnancy Test • HIV Test Kits • Ovulation predictor Test Kits • Cholesterol Detection Kits • Drug of Abuse Test Kits o Marijuana Kits o Opiates Kits o Benzodiazepines Kits o Alcohol Abuse Kits o Others • Others o Male infertility Test Kits o Urinary Tract Infections Test o Menopause Test Kits o Fecal Occult Blood Test o Others By Form Type • Cassette • Strip • Midstream • Digital Monitoring Instrument • Test Panel • Cup • Dip Card • Others By Sample Type • Blood • Urine • Saliva • Others By Usage • Disposable • Reusable By Distribution Channel • Retail Pharmacies • Drug Stores • Supermarket/Hypermarket • Online Pharmacies By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global At Home Diagnostics Market By Test Type, By Form Type, By Sample Type, By Usage, By Distribution Channel and by Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
At Home Diagnostics Market is calculated to value over USD 7.6 billion by the end of 2028 and register at a CAGR of over 5.4% during the forecast period of 2021-2028.
Tests that are performed on human body samples like blood, saliva and urine which can be used for detection of diseases or medical conditions at home are called in-vitro diagnostics or home diagnostics. It is a popular test among the patient population as these tests are cost-effective, quick and confidential. The home diagnostic system is found in the form of a strip, digital monitoring instruments, dip cards, cups and cassettes.
Growing awareness of home care testing among the population led to the potential growth of the market. Increasing epidemics of diseases has shifted the focus of the general population towards preventive healthcare rather than curative medicines. It created huge opportunities for manufacturers in this market. It is further augmented by changing demographics and increasing per capita healthcare expenditure due to increasing living standards led to the robust growth of the market. At home, diagnosis plays an important role in the preliminary diagnosis of disease and contained the cost of healthcare expenditure. As they are cost-effective and easy to use, patient adoption is high with limited technical knowledge. All these factors led to the burgeoning growth of the market
North America and Europe dominated the global market due to high awareness among the general population. In North America, US accounts 90% market share due to high adoption. In Europe, UK Germany and France dominated the global market due to high penetration among the general population. The Asia Pacific and Latin America is the most opportunistic market for manufacturers due to the large patient population. They both were expected to witness high growth rate during the forecast period. Rest of the World accounts the small fraction of the market and it is expected to account more share during the later phase of the forecast period.
Major players included in the At Home Diagnostics Market: • Thermo Fisher Scientific • SYNLAB • Siemens Healthcare Private Limited • Roche Diagnostics • Drägerwerk AG & Co. KGaA • Beckman Coulter, Inc. • Abbott Laboratories • ACON Laboratories Inc. • BTNX Inc. • ARKRAY Inc. • Assure Tech (Hangzhou) co. Ltd. • Bionime Corporation • Quidel Corporation • True Diagnostics Inc. (Note: The list of the major players will be updated with the latest market scenario and trends)
At Home Diagnostics Market Segmentation:
By Test Type • Glucose Monitoring Devices • Pregnancy Test • HIV Test Kits • Ovulation predictor Test Kits • Cholesterol Detection Kits • Drug of Abuse Test Kits o Marijuana Kits o Opiates Kits o Benzodiazepines Kits o Alcohol Abuse Kits o Others • Others o Male infertility Test Kits o Urinary Tract Infections Test o Menopause Test Kits o Fecal Occult Blood Test o Others
By Form Type • Cassette • Strip • Midstream • Digital Monitoring Instrument • Test Panel • Cup • Dip Card • Others
By Sample Type • Blood • Urine • Saliva • Others
By Usage • Disposable • Reusable
By Distribution Channel • Retail Pharmacies • Drug Stores • Supermarket/Hypermarket • Online Pharmacies
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the global At Home Diagnostics Market By Test Type, By Form Type, By Sample Type, By Usage, By Distribution Channel and by Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global At Home Diagnostics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of At Home Diagnostics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global At Home Diagnostics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global At Home Diagnostics Market, By Test Type Historical Analysis and Forecast 2021-2028 (USD Million) 7.1. Glucose Monitoring Devices 7.2. Pregnancy Test 7.3. HIV Test Kits 7.4. Ovulation predictor Test Kits 7.5. Cholesterol Detection Kits 7.6. Drug of Abuse Test Kits 7.6.1. Marijuana Kits 7.6.2. Opiates Kits 7.6.3. Benzodiazepines Kits 7.6.4. Alcohol Abuse Kits 7.6.5. Others 7.7. Others 7.7.1. Male infertility Test Kits 7.7.2. Urinary Tract Infections Test 7.7.3. Menopause Test Kits 7.7.4. Fecal Occult Blood Test 7.7.5. Others 8. Global At Home Diagnostics Market, By Form Type Historical Analysis and Forecast 2021-2028 (USD Million) 8.1. Cassette 8.2. Strip 8.3. Midstream 8.4. Digital Monitoring Instrument 8.5. Test Panel 8.6. Cup 8.7. Dip Card 8.8. Others 9. Global At Home Diagnostics Market, By Sample Type Historical Analysis and Forecast 2021-2028 (USD Million) 9.1. Blood 9.2. Urine 9.3. Saliva 9.4. Others 10. Global At Home Diagnostics Market, By Usage Historical Analysis and Forecast 2021-2028 (USD Million) 10.1. Disposable 10.2. Reusable 11. Global At Home Diagnostics Market, By Distribution Channel Historical Analysis and Forecast 2021-2028 (USD Million) 11.1. Retail Pharmacies 11.2. Drug Stores 11.3. Supermarket/Hypermarket 11.4. Online Pharmacies 12. North America At Home Diagnostics Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2021-2028 13. Latin America At Home Diagnostics Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2021-2028 14. Europe At Home Diagnostics Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2021-2028 15. Asia Pacific At Home Diagnostics Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028 16. Middle East and Africa Market Analysis 2016–2021 and Forecast 2021–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2021-2028 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Thermo Fisher Scientific 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. SYNLAB 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Siemens Healthcare Private Limited 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Roche Diagnostics 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Drägerwerk AG & Co. KGaA 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Beckman Coulter, Inc. 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Abbott Laboratories 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. ACON Laboratories Inc. 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. BTNX Inc. 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.ARKRAY Inc. 18.10.1.Company Overview 18.10.2.Product Portfolio 18.10.3.SWOT Analysis 18.10.4.Financial Overview 18.10.5.Strategic Overview 18.11.Assure Tech (Hangzhou) co. Ltd. 18.11.1.Company Overview 18.11.2.Product Portfolio 18.11.3.SWOT Analysis 18.11.4.Financial Overview 18.11.5.Strategic Overview 18.12.Bionime Corporation 18.12.1.Company Overview 18.12.2.Product Portfolio 18.12.3.SWOT Analysis 18.12.4.Financial Overview 18.12.5.Strategic Overview 18.13.Quidel Corporation 18.13.1.Company Overview 18.13.2.Product Portfolio 18.13.3.SWOT Analysis 18.13.4.Financial Overview 18.13.5.Strategic Overview 18.14.True Diagnostics Inc. 18.14.1.Company Overview 18.14.2.Product Portfolio 18.14.3.SWOT Analysis 18.14.4.Financial Overview 18.14.5.Strategic Overview 19. Pre and Post COVID-20 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-20 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global At Home Diagnostics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of At Home Diagnostics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global At Home Diagnostics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global At Home Diagnostics Market, By Test Type Historical Analysis and Forecast 2021-2028 (USD Million) 7.1. Glucose Monitoring Devices 7.2. Pregnancy Test 7.3. HIV Test Kits 7.4. Ovulation predictor Test Kits 7.5. Cholesterol Detection Kits 7.6. Drug of Abuse Test Kits 7.6.1. Marijuana Kits 7.6.2. Opiates Kits 7.6.3. Benzodiazepines Kits 7.6.4. Alcohol Abuse Kits 7.6.5. Others 7.7. Others 7.7.1. Male infertility Test Kits 7.7.2. Urinary Tract Infections Test 7.7.3. Menopause Test Kits 7.7.4. Fecal Occult Blood Test 7.7.5. Others
8. Global At Home Diagnostics Market, By Form Type Historical Analysis and Forecast 2021-2028 (USD Million) 8.1. Cassette 8.2. Strip 8.3. Midstream 8.4. Digital Monitoring Instrument 8.5. Test Panel 8.6. Cup 8.7. Dip Card 8.8. Others
9. Global At Home Diagnostics Market, By Sample Type Historical Analysis and Forecast 2021-2028 (USD Million) 9.1. Blood 9.2. Urine 9.3. Saliva 9.4. Others
10. Global At Home Diagnostics Market, By Usage Historical Analysis and Forecast 2021-2028 (USD Million) 10.1. Disposable 10.2. Reusable
11. Global At Home Diagnostics Market, By Distribution Channel Historical Analysis and Forecast 2021-2028 (USD Million) 11.1. Retail Pharmacies 11.2. Drug Stores 11.3. Supermarket/Hypermarket 11.4. Online Pharmacies
12. North America At Home Diagnostics Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2021-2028
13. Latin America At Home Diagnostics Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2021-2028
14. Europe At Home Diagnostics Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2021-2028
15. Asia Pacific At Home Diagnostics Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028
16. Middle East and Africa Market Analysis 2016–2021 and Forecast 2021–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2021-2028
17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix
18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Thermo Fisher Scientific 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. SYNLAB 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. Siemens Healthcare Private Limited 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Roche Diagnostics 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. Drägerwerk AG & Co. KGaA 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. Beckman Coulter, Inc. 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. Abbott Laboratories 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. ACON Laboratories Inc. 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. BTNX Inc. 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10.ARKRAY Inc. 18.10.1.Company Overview 18.10.2.Product Portfolio 18.10.3.SWOT Analysis 18.10.4.Financial Overview 18.10.5.Strategic Overview 18.11.Assure Tech (Hangzhou) co. Ltd. 18.11.1.Company Overview 18.11.2.Product Portfolio 18.11.3.SWOT Analysis 18.11.4.Financial Overview 18.11.5.Strategic Overview 18.12.Bionime Corporation 18.12.1.Company Overview 18.12.2.Product Portfolio 18.12.3.SWOT Analysis 18.12.4.Financial Overview 18.12.5.Strategic Overview 18.13.Quidel Corporation 18.13.1.Company Overview 18.13.2.Product Portfolio 18.13.3.SWOT Analysis 18.13.4.Financial Overview 18.13.5.Strategic Overview 18.14.True Diagnostics Inc. 18.14.1.Company Overview 18.14.2.Product Portfolio 18.14.3.SWOT Analysis 18.14.4.Financial Overview 18.14.5.Strategic Overview
19. Pre and Post COVID-20 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-20 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations
20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics